MarketCap
InMed Pharmaceuticals INM
€ 1.23
1.45%
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
4.16 M |
Marktkapitalisierung |
$ 5.83 M |
EBITDA (LTM) |
$ 205 K |
P/E (LTM) |
-0.598174 |
P/S (LTM) |
0.329468 |
EPS (LTM) |
-2.19 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
AnaptysBio
ANAB
|
$ 51.7 | 1.83 % | $ 1.5 B | Nasdaq Global Select Market,SPB |  USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.73 | 3.61 % | $ 258 M | Nasdaq Global Select Market |  Britain |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.89 | 0.53 % | $ 107 M | Nasdaq Global Select Market,SPB | USA |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | USA |
 |
Rezolute
RZLT
|
$ 3.94 | 1.87 % | $ 299 M | Nasdaq Capital Market | USA |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.52 | 1.17 % | $ 6.21 B | Nasdaq Capital Market |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 61.35 | 0.06 % | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Benitec Biopharma
BNTC
|
$ 9.64 | 0.46 % | $ 449 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 99.26 | 0.81 % | $ 24 B | Nasdaq Global Select Market |  Germany |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | USA |
 |
Burford Capital Limited
BUR
|
$ 3.63 | 3.93 % | $ 795 M | NYSE | Britain |
|
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 2.17 | 0.46 % | $ 3.57 M | NYSE American | Israel |
 |
Catalyst Biosciences
CBIO
|
$ 14.24 | 0.35 % | $ 1.27 B | Nasdaq Capital Market | USA |
 |
C4 Therapeutics
CCCC
|
$ 3.03 | 0.3 % | $ 251 M | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.37 | 1.45 % | $ 119 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.61 | 0.38 % | $ 497 M | Nasdaq Global Market | USA |
 |
AbbVie
ABBV
|
$ 265.12 | 0.09 % | $ 469 B | NYSE,SPB | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 1.17 | 1.48 % | $ 137 M | Nasdaq Global Market | USA |
 |
AbCellera Biologics
ABCL
|
$ 12.65 | 2.76 % | $ 3.78 B | Nasdaq Global Select Market | Canada |
 |
Abeona Therapeutics
ABEO
|
$ 5.43 | 2.65 % | $ 288 M | Nasdaq Capital Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 31.48 | 1.16 % | $ 2.09 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 4.12 | 1.98 % | $ 50.3 M | Nasdaq Capital Market | Israel |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
Cellectar Biosciences
CLRB
|
$ 2.08 | 0.48 % | $ 5.43 M | Nasdaq Capital Market | USA |
 |
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | Canada |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Cocrystal Pharma
COCP
|
$ 1.15 | 1.67 % | $ 13 M | Nasdaq Capital Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 22.64 | 0.85 % | $ 717 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 118.51 | 4.93 % | $ 12.3 B | Nasdaq Capital Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 7.45 | 0.19 % | $ 99.2 M | Nasdaq Global Market | USA |
 |
Curis
CRIS
|
$ 0.88 | 0.85 % | $ 11.6 M | Nasdaq Global Market | USA |
 |
CorMedix
CRMD
|
$ 7.77 | 1.04 % | $ 560 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 55.7 | 0.23 % | $ 5.01 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Corvus Pharmaceuticals
CRVS
|
$ 11.8 | 8.21 % | $ 932 M | Nasdaq Global Market | USA |
|
Champions Oncology
CSBR
|
$ 4.95 | 0.38 % | $ 68.5 M | Nasdaq Capital Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.88 | 0.62 % | $ 935 M | Nasdaq Global Select Market | Canada |
 |
Cue Biopharma
CUE
|
$ 32.85 | 3.6 % | $ 3.11 B | Nasdaq Capital Market,SPB | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.72 | 2.38 % | $ 13.8 M | NYSE American,SPB | USA |